Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 31.16 | -41.12 |
| PEG Ratio (TTM) | 1.09 | 1.95 |
| P/S Ratio (TTM) | 1.80 | 2.19 |
| P/B Ratio (TTM) | 1.74 | 0.43 |
| P/FCF Ratio (TTM) | -369.30 | 25.81 |
| Price to 5YR AVG Earnings Ratio | N/A | -79.74 |
| Price to 5YR AVG FCF Ratio | N/A | 11.06 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.99% | 2.06% |
| ROE (TTM) | 6.02% | 1.42% |
| Net Profit Margin (TTM) | 5.67% | 3.98% |
| ROIC 5YR AVG | N/A | 0.46% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 71.97% | -452.80% | N/A |
| Revenue | 4.50% | -0.83% | N/A |
| Net Income | 73.67% | -462.35% | N/A |
| Cash Flow | 15.21% | -13.64% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.59 | 1.09 |
| Quick Ratio (TTM) | 0.46 | 0.77 |
| D/E Ratio (TTM) | 0.64 | 0.86 |
| Interest Coverage (TTM) | 2.23 | 5.19 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 0.97 | 1.96 |
| LTL to 5YR AVG FCF | N/A | 0.33 |
| Shares Outstanding Growth 5YR AVG | N/A | 10.10% |